Senior Research Scientist, Machine Learning (BioFM)

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

A-Alpha Bio

A2 Biotherapeutics

AAVogen

ACELYRIN

ADAXION Therapeutics

AI Proteins

AIRNA Bio

ALX Oncology

AN2 Therapeutics

AOA Dx

ARTBIO

AS2 Bio Inc

AUM BioTech

AVROBIO

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

Acepodia

Achieve Life Sciences

Acomhal Research

Acrivon Therapeutics

Actym Therapeutics, Inc.

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Adiso Therapeutics

Aditum Bio

Admera Health

Adverum Biotechnologies

Aeglea BioTherapeutics

Aera Therapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

AgBiome

Agastiya Biotech

Agena Bioscience

AiViva Biopharma

Ainnocence

AivoCode

Aixa Bio

Akero Therapeutics

Akita Biosciences

Akouos

Akttyva Therapeutics

Alamar Biosciences

Aldebaran Therapeutics

Alector

Alida Biosciences

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Oncology

Alphabioregen

AltPep

Alterome Therapeutics

Altis Biosystems

Alto Neuroscience

Alumis

Alveo Technologies

Alveolus Bio

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AnHeart Therapeutics

Anagram Therapeutics

Ancora Biotech LLC

Andes

Andson Biotech

Anebulo Pharmaceuticals

Angiex

Angiocrine Bioscience

Anima Biotech

Ankyra

Annexon Biosciences

Anodyne Nanotech

Anokion

Ansa Biotechnologies

Antares Therapeutics

Deep Genomics is using AI to build life-saving genetic therapeutics. Biology is too complex for the human mind to comprehend, so future drug development will depend on AI assistance. By using the revolutions in AI, RNA biology and automation, Deep Genomics is designing RNA therapies for any gene and any genetic condition. Deep Genomics’ proprietary AI Workbench identifies novel targets from evaluating thousands of possibilities to identify the best therapeutic candidates. Lead candidates have been identified for over 50% of the novel targets Deep Genomics has tested so far. Now, Deep Genomics is creating AI Workbench 3.0 to expand the number of mechanisms and genetic variants analyzed, so the company can tackle complex genetic diseases.

<p>Deep Genomics is using AI to build life-saving genetic therapeutics. Biology is too complex for the human mind to comprehend, so future drug development will depend on AI assistance. By using the revolutions in AI, RNA biology and automation, Deep Genomics is designing RNA therapies for any gene and any genetic condition. Deep Genomics’ proprietary AI Workbench identifies novel targets from evaluating thousands of possibilities to identify the best therapeutic candidates. Lead candidates have been identified for over 50% of the novel targets Deep Genomics has tested so far. Now, Deep Genomics is creating AI Workbench 3.0 to expand the number of mechanisms and genetic variants analyzed, so the company can tackle complex genetic diseases.</p>


Find a biotech startup job.